U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Central heterochromia

MedGen UID:
867209
Concept ID:
C4021567
Sign or Symptom
Synonym: Ring iris heterochromia
 
HPO: HP:0007818

Definition

The presence of distinct colors in the central (pupillary) zone of the iris than in the mid-peripheral (ciliary) zone. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVCentral heterochromia

Conditions with this feature

Trichomegaly-retina pigmentary degeneration-dwarfism syndrome
MedGen UID:
338532
Concept ID:
C1848745
Disease or Syndrome
PNPLA6 disorders span a phenotypic continuum characterized by variable combinations of cerebellar ataxia; upper motor neuron involvement manifesting as spasticity and/or brisk reflexes; chorioretinal dystrophy associated with variable degrees of reduced visual function; and hypogonadotropic hypogonadism (delayed puberty and lack of secondary sex characteristics). The hypogonadotropic hypogonadism occurs either in isolation or as part of anterior hypopituitarism (growth hormone, thyroid hormone, or gonadotropin deficiencies). Common but less frequent features are peripheral neuropathy (usually of axonal type manifesting as reduced distal reflexes, diminished vibratory sensation, and/or distal muscle wasting); hair anomalies (long eyelashes, bushy eyebrows, or scalp alopecia); short stature; and impaired cognitive functioning (learning disabilities in children; deficits in attention, visuospatial abilities, and recall in adults). Some of these features can occur in distinct clusters on the phenotypic continuum: Boucher-Neuhäuser syndrome (cerebellar ataxia, chorioretinal dystrophy, and hypogonadotropic hypogonadism); Gordon Holmes syndrome (cerebellar ataxia, hypogonadotropic hypogonadism, and – to a variable degree – brisk reflexes); Oliver-McFarlane syndrome (trichomegaly, chorioretinal dystrophy, short stature, intellectual disability, and hypopituitarism); Laurence-Moon syndrome; and spastic paraplegia type 39 (SPG39) (upper motor neuron involvement, peripheral neuropathy, and sometimes reduced cognitive functioning and/or cerebellar ataxia).

Professional guidelines

PubMed

Li S, Qin M, Mao S, Mei L, Cai X, Feng Y, He C, Song J
BMC Med Genomics 2022 Nov 3;15(1):230. doi: 10.1186/s12920-022-01379-6. PMID: 36329483Free PMC Article

Recent clinical studies

Etiology

Edwards M, Cha D, Krithika S, Johnson M, Cook G, Parra EJ
Pigment Cell Melanoma Res 2016 Mar;29(2):141-62. Epub 2015 Dec 22 doi: 10.1111/pcmr.12435. PMID: 26547379

Clinical prediction guides

Edwards M, Cha D, Krithika S, Johnson M, Cook G, Parra EJ
Pigment Cell Melanoma Res 2016 Mar;29(2):141-62. Epub 2015 Dec 22 doi: 10.1111/pcmr.12435. PMID: 26547379

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...